Goldstein Advisors, LLC

Position in LLY — ELI LILLY & Co

CIK 1963807 Madison, WI

Position in LLY

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$629,700

+$145,901 QoQ

Shares Held

525

-0.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.62%

of 13F equity value

Holder Rank

#3,555

of 4,605 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Goldstein Advisors, LLC holds $3,737,042 across 6 Drug Manufacturers - General names. LLY ranks #3 (16.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	3,947	$1,002,419
2	ABBV	AbbVie Inc.	3,951	$994,229
3	LLY	ELI LILLY & Co This page	525	$629,700
4	MRK	Merck & Co., Inc.	4,434	$569,769
5	GILD	Gilead Sciences, Inc.	2,555	$322,798
6	NVO	Novo Nordisk A S	4,550	$218,127

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$629,700	525	-0.2%	Shares	Sole	2026-07-20
2026-03-31	$483,799	526	+4.0%	Shares	Sole	2026-04-28
2025-12-31	$543,788	506	-3.1%	Shares	Sole	2026-02-10
2025-09-30	$398,286	522	-17.9%	Shares	Sole	2025-10-21
2025-06-30	$495,781	636	-4.4%	Shares	Sole	2025-07-29
2025-03-31	$549,230	665	+6.1%	Shares	Sole	2025-04-23
2024-12-31	$484,044	627	-2.9%	Shares	Sole	2025-01-17
2024-09-30	$572,317	646	+2.5%	Shares	Sole	2024-10-24
2024-06-30	$570,389	630	-3.2%	Shares	Sole	2024-07-24
2024-03-31	$506,451	651	+2.5%	Shares	Sole	2024-05-13
2023-12-31	$370,154	635	+12.8%	Shares	Sole	2024-02-12
2023-09-30	$302,404	563	+6.0%	Shares	Sole	2023-10-18
2023-06-30	$249,028	531	-11.9%	Shares	Sole	2023-07-21
2022-12-31	$220,601	603	—	Shares	Sole	2023-02-03
No filing history on record for this holder in this stock.